Updated analysis from a phase 2 study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable/metastatic microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) solid tumors.

被引：0
作者：
Li, Jian
Xu, Ye
Zang, Aimin
Gao, Yunong
Gao, Quanli
Zhang, Yanqiao
Wang, Dong
Xu, Jianming
Yuan, Ying
Jiang, Haiping
Ying, Jieer
Shi, Chunmei
Deng, Yanhong
Wang, Jing
Liu, Tianshu
Huang, Yi
Xu, Yaling
Wang, Yidi
Fei, Cong
Shen, Lin
机构：
[1] Beijing Canc Hosp, Beijing, Peoples R China
[2] Fudan Univ Shanghai, Canc Ctr, Shanghai, Peoples R China
[3] Hebei Univ, Affiliated Hosp, Hebei, Peoples R China
[4] Henan Canc Hosp, Zhengzhou, Henan, Peoples R China
[5] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[6] Chongqing Univ, Canc Hosp, Chongqing, Peoples R China
[7] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China
[8] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Zhejiang, Peoples R China
[9] Med Sch Zhejiang Univ, Affiliated Hosp 1, Zhejiang, Peoples R China
[10] Zhejiang Canc Hosp, Beijing, Peoples R China
[11] Fujian Med Univ, Union Hop, Fujian, Peoples R China
[12] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
[13] Hunan Canc Hosp, Changsha, Hunan, Peoples R China
[14] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[15] Hubei Canc Hosp, Wuhan, Hubei, Peoples R China
[16] BeiGene Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14556
引用
收藏
页数：1
相关论文
共 50 条
[41]   Clinical efficacy and biomarker analysis of pucotenlimab (HX008) in patients with previously treated advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A single-arm, multicenter, phase 2 study. [J].
Zhang, Bo ;
Song, Yan ;
Luo, Suxia ;
Yin, Xianli ;
Li, Enxiao ;
Wang, Hui ;
He, Yifu ;
Liu, Zhihui ;
Fan, Qingxia ;
Liang, Xinjun ;
Shu, Yongqian ;
Liu, Yunpeng ;
Xu, Nong ;
Zhang, Shu ;
Zhuang, Zhixiang ;
Zhang, Jingdong ;
Kou, Xiaoge ;
Wang, Fen ;
Zhu, Xiaodong ;
Huang, Jing .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 :799-799
[42]   Final overall survival for the phase III KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC). [J].
Andre, Thierry ;
Shiu, Kai-Keen ;
Kim, Tae Won ;
Jensen, Benny Vittrup ;
Jensen, Lars Henrik ;
Punt, Cornelis J. A. ;
Smith, Denis Michel ;
Garcia-Carbonero, Rocio ;
Alcaide, Julia ;
Gibbs, Peter ;
De la Fouchardiere, Christelle ;
Rivera, Fernando ;
Elez, Elena ;
Bendell, Johanna C. ;
Le, Dung T. ;
Yoshino, Takayuki ;
Zhong, Wen Yan ;
Fogelman, David R. ;
Marinello, Patricia ;
Diaz, Luis A. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[43]   Primary analysis of GEICO 120/DORA, a real-world multicentre study of dostarlimab in patients with recurrent or advanced DNA mismatch repair deficient/microsatellite instability-high (DMMR/MSI-H) endometrial cancer [J].
Gallego, Alejandro ;
Madariaga, Ainhoa ;
Estevez-Garcia, Purificacion ;
Alberti, Facundo ;
Carbo, Anna ;
Palacio, Isabel ;
Churruca, Cristina ;
Galvez, Fernando ;
Ortega, M. Eugenia ;
Murata, Paola ;
Manzano, Aranzazu ;
Masvidal, Maria ;
Martin-Lorente, Cristina ;
Hernando, Blanca ;
Lozano, Inmaculada ;
Cueva, Juan F. ;
Garcia-Illescas, David ;
Falco, Esther ;
Mendiola, Marta ;
Redondo, Andres .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) :A182-A182
[44]   Dostarlimab in advanced/recurrent (AR) mismatch repair deficient/microsatellite instability-high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC): The GARNET study. [J].
Oaknin, Ana ;
Pothuri, Bhavana ;
Gilbert, Lucy ;
Sabatier, Renaud ;
Ghamande, Sharad A. ;
Gravina, Adriano ;
Calvo, Emiliano ;
Banerjee, Susana N. ;
Miller, Rowan ;
Pikiel, Joanna ;
Mirza, Mansoor Raza ;
Duan, Tao ;
Zildjian, Sybil ;
Zografos, Eleftherios ;
Veneris, Jennifer Taylor ;
Tinker, Anna ;
Powell, Matthew A. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[45]   RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab combination in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC): Results of the GERCOR NIPICOL phase II study [J].
Cohen, Romain ;
Bennouna, Jaafar ;
Henriques, Julie ;
Tournigand, Christophe ;
De La Fouchardiere, Christelle ;
Tougeron, David ;
Borg, Christophe ;
Mazard, Thibault ;
Chibaudel, Benoist ;
Garcia-Larnicol, Marie-Line ;
Svrcek, Magali ;
Vernerey, Dewi ;
Menu, Yves ;
Andre, Thierry .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[46]   Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the randomized phase III KEYNOTE-177 study [J].
Shiu, K. K. ;
Andre, T. ;
Kim, T. W. ;
Jensen, B. Vittrup ;
Jensen, L. H. ;
Punt, C. J. A. ;
Smith, D. ;
Garcia-Carbonero, R. ;
Alcaide-Garcia, J. ;
Gibbs, P. ;
De la Fouchardiere, C. ;
Rivera, F. ;
Fernandez, M. E. Elez ;
Le, D. T. ;
Yoshino, T. ;
Zuo, Y. ;
Fogelman, D. ;
Adelberg, D. E. ;
Diaz, L. A. .
ANNALS OF ONCOLOGY, 2023, 34 :S1271-S1272
[47]   Camrelizumab in advanced or metastatic solid tumor patients with microsatellite instability-high/mismatch repair-deficient: Results from an open-label exploratory study. [J].
Chen, Jingde ;
Quan, Ming ;
Chen, Zhiqin ;
Zeng, Tianmei ;
Li, Yandong ;
Zhou, Ying ;
Hai, Yanan ;
Gao, Yong .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[48]   Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H) [J].
Berton-Rigaud, D. ;
Pautier, P. ;
Lorusso, D. ;
Gennigens, C. ;
Gladieff, L. ;
Kryzhanivska, A. ;
Bowman, J. ;
Tian, C. ;
Cornfeld, M. ;
Van Gorp, T. .
ANNALS OF ONCOLOGY, 2023, 34 :S517-S517
[49]   Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study. [J].
Qin, Shukui ;
Li, Jin ;
Zhong, Haijun ;
Jin, Chuan ;
Chen, Lili ;
Yuan, Xianglin ;
Fan, Qingxia ;
Chen, Kehe ;
Cao, Peiguo ;
Xiao, Jianjun ;
Jiang, Da ;
Zhang, Tao ;
Zhang, Hongyu ;
Wang, Xicheng ;
Wang, Wei ;
Wang, Qingyu .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[50]   The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world. [J].
Chakrabarti, Sakti ;
Parish, Marie ;
Peterson, Carrie ;
Ludwig, Kirk A. ;
Sriram, Deepika ;
Ruggeri, Antony ;
Tolay, Sameer ;
Selfridge, Jennifer Eva ;
Bajor, David L. ;
Mohamed, Amr ;
Mahipal, Amit ;
Shreenivas, Aditya V. .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 :105-105
12345